GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we approach type 2 diabetes . These prescription therapies function to mimicking the body’s https://dirstop.com/story29208577/glp-1-a-major-approach-in-glucose-treatment